Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.025 USD | +3.95% | +1.69% | -9.34% |
Apr. 12 | Piper Sandler Adjusts Price Target on Century Therapeutics to $9 From $10, Maintains Overweight Rating | MT |
Apr. 11 | Syncona agrees to sell stake in investee company for GBP7.4 million | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.34% | 240M | |
+0.11% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.73% | 24.63B | |
-23.34% | 18.2B | |
+27.90% | 12.01B | |
-2.66% | 11.76B | |
+14.28% | 10.4B | |
-5.13% | 9.94B |
- Stock Market
- Equities
- IPSC Stock
- News Century Therapeutics, Inc.
- Piper Sandler Adjusts Price Target on Century Therapeutics to $9 From $10, Maintains Overweight Rating